Innoviva (INVA) Amortization of Deferred Charges (2013 - 2026)
Innoviva posted quarterly Amortization of Deferred Charges of $364000.0 for Q1 2026, down 32.72% year-on-year from $541000.0 in Q1 2025, and down 76.26% on a QoQ basis from $1.5 million in Q3 2025.
Innoviva (INVA) has 14 years of Amortization of Deferred Charges data on file, last reported at $364000.0 in Q1 2026.
- For the quarter ending Q1 2026, Amortization of Deferred Charges fell 32.72% year-over-year to $364000.0; the trailing twelve-month figure through Mar 2026 stood at $3.0 million (down 6.15% YoY), and the FY2025 full-year result was $1.9 million, down 10.57% from the prior year.
- Amortization of Deferred Charges for Q1 2026 stood at $364000.0, down from $1.5 million in the prior quarter.
- Across five years, Amortization of Deferred Charges topped out at $1.6 million in Q3 2024 and bottomed at $364000.0 in Q1 2026.
- The 5-year median for Amortization of Deferred Charges is $537000.0 (2025), against an average of $815923.1.
- The widest annual swing landed in 2022, when Amortization of Deferred Charges plunged 82.95%; it then surged 38.73% in 2023.
- A 5-year view of Amortization of Deferred Charges shows it stood at $1.5 million in 2022, then rose by 3.89% to $1.5 million in 2023, then increased by 2.07% to $1.6 million in 2024, then decreased by 3.04% to $1.5 million in 2025, then slumped by 76.26% to $364000.0 in 2026.
- The last three Amortization of Deferred Charges figures came in at $364000.0 (Q1 2026), $1.5 million (Q3 2025), and $537000.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Innoviva | 1.60 Bn | 992.84 Mn | 75.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 364,000.00 |
| Mar 31, 2026 | 364,000.00 |
| Sep 30, 2025 | 1.53 Mn |
| Sep 30, 2025 | 1.53 Mn |
| Jun 30, 2025 | 537,000.00 |
| Jun 30, 2025 | 537,000.00 |
| Mar 31, 2025 | 541,000.00 |
| Mar 31, 2025 | 541,000.00 |
| Sep 30, 2024 | 1.58 Mn |
| Sep 30, 2024 | 1.58 Mn |
| Jun 30, 2024 | 523,000.00 |
| Jun 30, 2024 | 523,000.00 |
| Mar 31, 2024 | 525,000.00 |
| Mar 31, 2024 | 525,000.00 |
| Sep 30, 2023 | 1.55 Mn |
| Sep 30, 2023 | 1.55 Mn |
| Jun 30, 2023 | 509,000.00 |
| Jun 30, 2023 | 509,000.00 |
| Mar 31, 2023 | 523,000.00 |
| Mar 31, 2023 | 523,000.00 |
| Sep 30, 2022 | 1.49 Mn |
| Sep 30, 2022 | 1.49 Mn |
| Jun 30, 2022 | 554,000.00 |
| Jun 30, 2022 | 554,000.00 |
| Mar 31, 2022 | 377,000.00 |
| Mar 31, 2022 | 377,000.00 |
| Sep 30, 2021 | 6.78 Mn |
| Sep 30, 2021 | 6.78 Mn |
| Jun 30, 2021 | 2.26 Mn |
| Jun 30, 2021 | 2.26 Mn |
| Mar 31, 2021 | 2.21 Mn |
| Mar 31, 2021 | 2.21 Mn |
| Dec 31, 2020 | 2.17 Mn |
| Dec 31, 2020 | 2.17 Mn |
| Sep 30, 2020 | 2.12 Mn |
| Sep 30, 2020 | 2.12 Mn |
| Jun 30, 2020 | 2.08 Mn |
| Jun 30, 2020 | 2.08 Mn |
| Mar 31, 2020 | 2.03 Mn |
| Mar 31, 2020 | 2.03 Mn |
| Dec 31, 2019 | 2.01 Mn |
| Dec 31, 2019 | 2.01 Mn |
| Sep 30, 2019 | 1.97 Mn |
| Sep 30, 2019 | 1.97 Mn |
| Jun 30, 2019 | 1.93 Mn |
| Jun 30, 2019 | 1.93 Mn |
| Mar 31, 2019 | 1.89 Mn |
| Mar 31, 2019 | 1.89 Mn |
| Dec 31, 2018 | 1.85 Mn |
| Dec 31, 2018 | 1.85 Mn |
| Sep 30, 2018 | 1.87 Mn |
| Sep 30, 2018 | 1.87 Mn |
| Jun 30, 2018 | 1.94 Mn |
| Jun 30, 2018 | 1.94 Mn |
| Mar 31, 2018 | 2.09 Mn |
| Mar 31, 2018 | 2.09 Mn |
| Dec 31, 2017 | 2.16 Mn |
| Dec 31, 2017 | 2.16 Mn |
| Sep 30, 2017 | 1.55 Mn |
| Sep 30, 2017 | 1.55 Mn |
| Jun 30, 2017 | 714,000.00 |
| Jun 30, 2017 | 714,000.00 |
| Mar 31, 2017 | 687,000.00 |
| Mar 31, 2017 | 687,000.00 |
| Dec 31, 2016 | 709,000.00 |
| Dec 31, 2016 | 709,000.00 |
| Sep 30, 2016 | 724,000.00 |
| Sep 30, 2016 | 724,000.00 |
| Jun 30, 2016 | 715,000.00 |
| Jun 30, 2016 | 715,000.00 |
| Mar 31, 2016 | 699,000.00 |
| Mar 31, 2016 | 699,000.00 |
| Dec 31, 2015 | 647,000.00 |
| Dec 31, 2015 | 647,000.00 |
| Sep 30, 2015 | 769,000.00 |
| Sep 30, 2015 | 769,000.00 |
| Jun 30, 2015 | 763,000.00 |
| Jun 30, 2015 | 763,000.00 |
| Mar 31, 2015 | 764,000.00 |
| Mar 31, 2015 | 764,000.00 |
| Dec 31, 2014 | 858,000.00 |
| Dec 31, 2014 | 858,000.00 |
| Sep 30, 2014 | 1.55 Mn |
| Sep 30, 2014 | 1.55 Mn |
| Dec 31, 2013 | 159,000.00 |
| Dec 31, 2013 | 159,000.00 |